Disease | Incidence Estimate | US people estimate | Statistic Used for Calculation |
| Mitochondrial disorders |
N/A |
N/A |
No information
|
| Metabolic disorders |
N/A |
N/A |
No information
|
| Aging |
N/A |
N/A |
No information
|
| Diabetes |
approx 1 in 340 or 0.29% or 798,000 people in USA |
797,999 |
approximately 798,000 new cases diagnosed annually in USA (CDC-OC)
|
| Insulin Resistance |
N/A |
N/A |
No information
|
| Metabolic Syndrome |
N/A |
N/A |
No information
|
| Systemic lupus erythematosus |
N/A |
N/A |
No information
|
| Diabetes Insipidus |
approx 1 in 6,666 or 0.01% or 40,800 people in USA |
40,799 |
less than 15 per 100,000 hospitalized patients
|
| Cushing's syndrome |
approx 1 in 100,000 or 0.00% or 2,720 people in USA |
2,720 |
estimated 10 to 15 per million people develop Cushing’s syndrome each year in the US (NIDDK, NIH, 2002)
|
| Hypertension |
N/A |
N/A |
No information
|
| Hypercholesterolemia |
N/A |
N/A |
No information
|
| Hemochromatosis |
N/A |
N/A |
No information
|
| Wilson's Disease |
N/A |
N/A |
No information
|
| Addisonian crisis |
N/A |
N/A |
No information
|
| Alkalosis |
N/A |
N/A |
No information
|
| Acidosis |
N/A |
N/A |
No information
|
| Anaphylaxis |
N/A |
N/A |
No information
|
| Hangover |
N/A |
N/A |
No information
|
| Pituitary conditions |
N/A |
N/A |
No information
|
| Atherosclerosis |
N/A |
N/A |
No information
|
| Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 17 |
N/A |
N/A |
No information
|
| Physical conditions |
N/A |
N/A |
No information
|
| Chronic Illness |
N/A |
N/A |
No information
|
| Paralysis |
N/A |
N/A |
No information
|
| Multiple Sclerosis, Susceptibility To, 1 |
N/A |
N/A |
No information
|
| Multiple Sclerosis, Susceptibility To, 2 |
N/A |
N/A |
No information
|
| Multiple Sclerosis, Susceptibility To, 3 |
N/A |
N/A |
No information
|
| Multiple Sclerosis, Susceptibility To, 4 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 12 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 11 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 10 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 9 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 8 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 7 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 6 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 5 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 4 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 3 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 2 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 1 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus with Vitiligo, Susceptibility to, 1 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus with Hemolytic Anemia, Susceptibility to, 1 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus with Nephritis, Susceptibility to, 1 |
N/A |
N/A |
No information
|
| Systemic Lupus Erythematosus, Susceptibility to, 13 |
N/A |
N/A |
No information
|
| Metabolic syndrome (syndrome X) |
N/A |
N/A |
No information
|
| Cushing's syndrome-induced hypertension |
N/A |
N/A |
No information
|
| Systemic lupus erythematoses |
N/A |
N/A |
No information
|
| Bullous systemic lupus erythematosus |
N/A |
N/A |
No information
|
| Volume depletion |
N/A |
N/A |
No information
|
| Dehydration |
N/A |
N/A |
No information
|
| Relapsing/remitting multiple sclerosis |
N/A |
N/A |
No information
|
| Secondary chronic progressive multiple sclerosis |
N/A |
N/A |
No information
|
| Primary progressive multiple sclerosis |
N/A |
N/A |
No information
|
| Marburg multiple sclerosis |
N/A |
N/A |
No information
|
| Optic-spinal form of multiple sclerosis |
N/A |
N/A |
No information
|
| Accidental death |
approx 1 in 2,906 or 0.03% or 93,591 people in USA |
93,591 |
93,592 annual cases in 2000 (CDC); 97,860 annual cases in 1999 (NVSR Sep 2001)
|
| Maternal death |
approx 1 in 695,652 or 0.00% or 391 people in USA |
391 |
391 women in 1999 (NVSR Sep 2001)
|
| Systemic Juvenile Rheumatoid Arthritis |
N/A |
N/A |
No information
|
| Tuberous sclerosis |
N/A |
N/A |
No information
|
| Balo disease |
N/A |
N/A |
No information
|
| Autoimmune Vasculitis |
N/A |
N/A |
No information
|
| Autoimmune Atherosclerosis |
N/A |
N/A |
No information
|
| Metabolic Acidosis |
N/A |
N/A |
No information
|
| Multiple Sclerosis |
N/A |
N/A |
No information
|
| Systemic candidiasis |
N/A |
N/A |
No information
|
| Systemic mastocytosis |
N/A |
N/A |
No information
|
| Shock, Cardiogenic |
N/A |
N/A |
No information
|
| Shock, Hypovolaemic |
N/A |
N/A |
No information
|
| Shock, Neurogenic |
N/A |
N/A |
No information
|
| Shock, Septic |
N/A |
N/A |
No information
|
| Shock, Traumatic |
N/A |
N/A |
No information
|
| Shock, Obstructive |
N/A |
N/A |
No information
|
| Shock, anaphylactic |
N/A |
N/A |
No information
|
| Shock, Endocrine |
N/A |
N/A |
No information
|
| Shock, Distributive |
N/A |
N/A |
No information
|
| Wasting Syndrome |
N/A |
N/A |
No information
|
| Water Intoxication |
N/A |
N/A |
No information
|
| Systemic monochloroacetate poisoning |
N/A |
N/A |
No information
|
| Glaucoma associated with systemic abnormalities |
N/A |
N/A |
No information
|
| Renal failure-like electrolyte imbalances |
N/A |
N/A |
No information
|
| Excessive diaphoresis |
N/A |
N/A |
No information
|
| AIDS wasting syndrome |
N/A |
N/A |
No information
|
| Acute rheumatic fever |
approx 1 in 83 or 1.20% or 3.3 million people in USA |
3,264,000 |
12 per 1000 (NHIS95)
|
| Anoxemia |
N/A |
N/A |
No information
|
| Anoxia |
N/A |
N/A |
No information
|
| Polyarthritis, systemic |
N/A |
N/A |
No information
|
| Portuguese type amyloidosis |
N/A |
N/A |
No information
|
| Hereditary amyloidosis |
N/A |
N/A |
No information
|
| Primary amyloidosis |
N/A |
N/A |
No information
|
| Dialysis-related amyloidosis |
N/A |
N/A |
No information
|
| Amyloidosis |
N/A |
N/A |
No information
|
| A ?-protein amyloidosis |
N/A |
N/A |
No information
|
| Amyloidosis AL |
N/A |
N/A |
No information
|
| Amyloidosis beta2-microglobulinic |
N/A |
N/A |
No information
|
| Amyloidosis, inflammatory |
N/A |
N/A |
No information
|
| Immunoglobulinic amyloidosis |
N/A |
N/A |
No information
|
| Rheumatic fever |
approx 1 in 83 or 1.20% or 3.3 million people in USA |
3,264,000 |
12 per 1000 (NHIS95)
|
| Hereditary carnitine deficiency syndrome, systemic |
N/A |
N/A |
No information
|
| Leukocytoclastic angiitis -- systemic |
N/A |
N/A |
No information
|
| Familial Granulomatosis, Blau type |
N/A |
N/A |
No information
|
| Familial, Systemic, Juvenile Granulomatosis |
N/A |
N/A |
No information
|
| Systemic Capillary Leak Syndrome |
N/A |
N/A |
No information
|
| Scleroderma, systemic |
N/A |
N/A |
No information
|
| Spontaneous periodic hypothermia |
N/A |
N/A |
No information
|
| Hyalinosis, infantile systemic |
N/A |
N/A |
No information
|
| Aggressive systemic mastocytosis |
N/A |
N/A |
No information
|
| Cushing syndrome, familial |
N/A |
N/A |
No information
|
| Diffuse systemic sclerosi |
N/A |
N/A |
No information
|
The medical term 'incidence' of Systemic disorders usually refers
to the annual diagnosis rate of new cases of Systemic disorders.
Prevalence is a different medical disease measure that refers
to the estimated population
of people who are managing Systemic disorders at any given time (e.g. prevalence includes people who have had
a medical condition for a long time).
For more information on prevalence and incidence statistics, see about prevalence and incidence statistics.